Potrero Capital Amends Form D/A, Confirms 3(c)(7) Exempt Status
| Field | Detail |
|---|---|
| Company | Potrero Capital Research Partners II, L.P. |
| Form Type | D/A |
| Filed Date | Mar 24, 2026 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $1, $1,000,000, $5,000,000, $1,000,001, $5,000,001 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: amendment, exempt-offering, regulatory-filing, private-fund
TL;DR
**Potrero Capital just confirmed its fund is for rich investors only, operating under 3(c)(7).**
AI Summary
Potrero Capital Research Partners II, L.P. filed an amended Form D/A on March 24, 2026, updating its notice of exempt offering. This filing specifically indicates that the fund operates under Section 3(c)(7) of the Investment Company Act, meaning it caters to highly sophisticated investors (qualified purchasers). For existing or potential investors, this confirms the fund's regulatory status and its focus on a specific, high-net-worth investor base, which implies a certain risk tolerance and investment strategy.
Why It Matters
This filing clarifies Potrero Capital Research Partners II, L.P.'s regulatory framework, confirming it's an exempt fund for qualified purchasers, which impacts who can invest and how it's regulated.
Risk Assessment
Risk Level: low — This is an administrative amendment to a filing, not indicating any new offering or significant change in business operations, thus posing low risk.
Analyst Insight
Investors should note this filing confirms the fund's regulatory status and target investor base (qualified purchasers), which is important for understanding its operational framework and investment strategy. No immediate action is required based on this administrative update.
Key Numbers
- 2026-03-24 — Filing Date (The date the D/A form was filed and accepted by the SEC.)
- 3(c)(7) — Investment Company Act Section (The specific exemption under which the fund operates, indicating it serves qualified purchasers.)
Key Players & Entities
- Potrero Capital Research Partners II, L.P. (company) — the filer of the D/A form
- 0001572224 (company) — CIK of the filer
- DE (company) — State of Incorporation for Potrero Capital Research Partners II, L.P.
FAQ
What is the purpose of this D/A filing by Potrero Capital Research Partners II, L.P.?
This D/A filing, dated March 24, 2026, is an amendment to a Notice of Exempt Offering of Securities. It specifically updates Item 3C to confirm the fund operates under Section 3(c)(7) of the Investment Company Act.
What does operating under Section 3(c)(7) mean for Potrero Capital Research Partners II, L.P.?
Operating under Section 3(c)(7) means that Potrero Capital Research Partners II, L.P. is an investment company that is exempt from registration under the Investment Company Act of 1940 because its outstanding securities are owned exclusively by 'qualified purchasers' and it is not making a public offering of its securities.
Filing Stats: 1,345 words · 5 min read · ~4 pages · Grade level 17.9 · Accepted 2026-03-24 09:17:22
Key Financial Figures
- $1 — enues No Aggregate Net Asset Value $1 - $1,000,000 $1 - $5,000,000 $1,000,
- $1,000,000 — No Aggregate Net Asset Value $1 - $1,000,000 $1 - $5,000,000 $1,000,001 - $5,000,
- $5,000,000 — Net Asset Value $1 - $1,000,000 $1 - $5,000,000 $1,000,001 - $5,000,000 $5,000,001
- $1,000,001 — e $1 - $1,000,000 $1 - $5,000,000 $1,000,001 - $5,000,000 $5,000,001 - $25,000,000
- $5,000,001 — $5,000,000 $1,000,001 - $5,000,000 $5,000,001 - $25,000,000 $5,000,001 - $25,000,000
- $25,000,000 — $1,000,001 - $5,000,000 $5,000,001 - $25,000,000 $5,000,001 - $25,000,000 $25,000,001
- $25,000,001 — $25,000,000 $5,000,001 - $25,000,000 $25,000,001 - $50,000,000 $25,000,001 - $100,000,0
- $50,000,000 — 5,000,001 - $25,000,000 $25,000,001 - $50,000,000 $25,000,001 - $100,000,000 $50,000,0
- $100,000,000 — 25,000,001 - $50,000,000 $25,000,001 - $100,000,000 $50,000,001 - $100,000,000 Over $1
- $50,000,001 — 0,000,000 $25,000,001 - $100,000,000 $50,000,001 - $100,000,000 Over $100,000,000 O
Filing Documents
- primary_doc.html (D/A)
- primary_doc.xml (D/A) — 9KB
- 0001572224-26-000001.txt ( ) — 11KB
From the Filing
Form D FORM D Notice of Exempt Offering of Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. OMB APPROVAL OMB Number: 3235-0076 Estimated Average burden hours per response: 4.0 1. Issuer's Identity CIK (Filer ID Number) Previous Name(s) None Entity Type Corporation Limited Partnership Limited Liability Company General Partnership Business Trust Other Name of Issuer Potrero Capital Research Partners II, L.P. Jurisdiction of Incorporation/Organization DELAWARE Year of Incorporation/Organization Over Five Years Ago Within Last Five Years (Specify Year) Yet to Be Formed 2. Principal Place of Business and Contact Information Name of Issuer Potrero Capital Research Partners II, L.P. Street Address 1 Street Address 2 235 MONTGOMERY STREET, SUITE 1010 SAN FRANCISCO CALIFORNIA 94104 415-576-1103 3. Related Persons Last Name First Name Middle Name Potrero Capital Research, LLC -- Street Address 1 Street Address 2 235 MONTGOMERY STREET SUITE 1010 SAN FRANCISCO CALIFORNIA 94104 Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) General Partner Last Name First Name Middle Name Ripsteen Jack Street Address 1 Street Address 2 235 MONTGOMERY STREET SUITE 1010 SAN FRANCISCO CALIFORNIA 94104 Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) Managing Member of Potrero Capital Research, LLC 4. Industry Group Agriculture Banking & Financial Services Commercial Banking Insurance Investing Investment Banking Pooled Investment Fund Hedge Fund Other Investment Fund Private Equity Fund Venture Capital Fund *Is the issuer registered as an investment company under the Investment Company Act of 1940? Yes No Other Banking & Financial Services Business Services Energy Coal Mining Electric Utilities Energy Conservation Environmental Services Oil & Gas Other Energy Health Care Biotechnology Health Insurance Hospitals & Physicians Pharmaceuticals Other Health Care Manufacturing Real Estate Commercial Construction REITS & Finance Residential Other Real Estate Retailing Restaurants Technology Computers Telecommunications Other Technology Travel Airlines & Airports Lodging & Conventions Tourism & Travel Services Other Travel Other 5. Issuer Size Revenue Range Aggregate Net Asset Value Range No Revenues No Aggregate Net Asset Value $1 - $1,000,000 $1 - $5,000,000 $1,000,001 - $5,000,000 $5,000,001 - $25,000,000 $5,000,001 - $25,000,000 $25,000,001 - $50,000,000 $25,000,001 - $100,000,000 $50,000,001 - $100,000,000 Over $100,000,000 Over $100,000,000 Decline to Disclose Decline to Disclose Not Applicable Not Applicable 6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply) Rule 504(b)(1) (not (i), (ii) or (iii)) Rule 506(b) Rule 504 (b)(1)(i) Rule 506(c) Rule 504 (b)(1)(ii) Securities Act Section 4(a)(5) Rule 504 (b)(1)(iii) Investment Company Act Section 3(c) Section 3(c)(1) Section 3(c)(9) Section 3(c)(2) Section 3(c)(10) Section 3(c)(3) Section 3(c)(11) Section 3(c)(4) Section 3(c)(12) Section 3(c)(5) Section 3(c)(13) Section 3(c)(6) Section 3(c)(14) Section 3(c)(7) 7. Type of Filing New Notice Date of First Sale 2013-04-01 First Sale Yet to Occur Amendment 8. Duration of Offering Does the Issuer intend this offering to last more than one year? Yes No 9. Type(s) of Securities Offered (select all that apply) Pooled Investment Fund Interests Equity Tenant-in-Common Securities Debt Mineral Property Securities Option, Warrant or Other Right to Acquire Another Security Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security Other (describe) Limited Partnership Interests 10. Business Combination Transaction Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? Yes No Clarification of Response (if Necessary) 11. Minimum Investment Minimum investment accepted from any outside investor $ 0 USD 12. Sales Compensation Recipient Recipient CRD Number None Gordian Investments, LLC 158611 (Associated) Broker or Dealer None (Associated) Broker or Dealer CRD Number None Gordian Investments, LLC 158611 Street Address 1 Street Address 2 3738 Mt. Diablo Blvd. Suite 301 Lafayette CALIFORNIA 94549 CALIFORNIA COLORADO DELAWARE FLORIDA ILLINOIS MARYLAND MASSACHUSETTS MICHIGAN NEVADA NEW YORK PENNSYLVANIA TEXAS UTAH Recipient Recipient CRD Number None Uhlmann Price Securities, LLC 42854 (Associated) Broke